487
Views
3
CrossRef citations to date
0
Altmetric
Review Articles

Projection of future numbers of mesothelioma cases in the US and the increasing prevalence of background cases: an update based on SEER data for 1975 through 2018

Pages 317-324 | Received 16 Feb 2022, Accepted 20 May 2022, Published online: 19 Jul 2022

References

  • Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL. 2018. Malignant mesothelioma and its non-asbestos causes. Arch Pathol Lab Med. 142(6):753–760.
  • Browne K. 1983. The epidemiology of mesothelioma. J Soc Occup Med. 33:190–194.
  • Finkelstein MM. 1983. Mortality among long-term employees of an Ontario asbestos-cement factory. Br J Ind Med. 40:138–144.
  • Gibbs AR. 1990. Role of asbestos and other fibres in the development of diffuse malignant mesothelioma. Thorax. 45(9):649–654.
  • Glynn ME, Keeton KA, Gaffney SH, Sahmel J. 2018. Ambient asbestos fiber concentrations and long-term trends in pleural mesothelioma incidence between urban and rural areas in the United States (1973–2012). Risk Analysis. 38(3):454–471.
  • Gordon R, Fitzgerald S, Millette J. 2014. Asbestos in commercial cosmetic talcum powder as a cause of mesothelioma in women. Int J Occup Environ Health. 20(4):318–332.
  • Hughes J, Weill H, Hammad YY. 1987. Mortality of workers employed in two asbestos cement manufacturing plants. Br J Ind Med. 44:161–174.
  • Ilgren EB, Wagner JC. 1991. Background incidence of mesothelioma: animal and human evidence. Regul Toxicol Pharmacol. 13(2):133–149.
  • Lane FC. 1951. Ships for victory, a history of shipbuilding under the U.S. maritime commission in World War II. Baltimore, MD: Johns Hopkins University.
  • Lerman Y, Learman Y, Schachter P, Herceg E, Lieberman Y, Yellin A. 1991. Radiation associated with malignant pleural mesothelioma. Thorax. 46:463–464.
  • McDonald JC. 1985. Health implications of environmental exposure to asbestos. Environ Health Perspect. 62:319–328.
  • McDonald JC, McDonald AD. 1996. The epidemiology of mesothelioma in historical context. Eur Respir J. 9:1932–1942.
  • Moline J, Bevilacqua K, Alexandri M, Gordon R. 2020. Mesothelioma associated with the use of cosmetic talc. Am Coll Occup Environ Med. 62(1):11–17.
  • Moolgavkar SH, Meza R, Turim J. 2009. Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005. Cancer Causes Control. 20(6):935–944.
  • Peterson JT, Greenberg DS, Buffler PA. 1984. Non-asbestos-related malignant mesothelioma: a review. Cancer. 54:951–960.
  • Peto J, Henderson BE, Pike MC. 1981. Trends in mesothelioma incidence in the United States and the forecast epidemic due to asbestos exposure during World War II. Banbury Report 9: Quantification of Occupational Cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 51–69.
  • Price B, Ware A. 2009. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005. Crit Rev Toxicol. 39(7):576–588.
  • Rothman J, Greenland S, Lash TL. 2008. Modern epidemiology 3rd edition. Philadelphia: Lippincott Williams & Wilkins.
  • Seidman H, Selikoff IJ, Gelb SK. 1986. Mortality experience of amosite asbestos factory workers: dose-response relationships 5 to 40 years after onset of short -term work experience. Am J Indus Med 10:479–514.
  • Seidman H. 1984. Short-term asbestos work exposure and long-term observation – July 1984 updating. Department of Epidemiology and Statistics. New York: American Cancer Society; p. 10001.
  • Selikoff IJ, Churg J, Cuyler Hammond E. 1965. Relationship between exposure to asbestos and mesothelioma. NEJM. 272(11):560–565.
  • Selikoff IJ, Hammond EC, Seidman H. 1979. Mortality experience of insulation workers in the United States and Canada, 1943-1976. Ann N Y Acad Sci. 330:91–116.
  • Siemiatycki J, Boffetta P. 1998. Invited commentary: is it possible to investigate the quantitative relation between asbestos and mesothelioma in a community-based study. Am J Epidemiol. 148(2):143–147.
  • Spirtas R, Heineman EF, Bernstein L, Beebe GW, Keehn RJ, Stark A, Harlow BL, Benichou J. 1994. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med. 51:804–811.
  • Taubes G. 1995. Epidemiology faces its limits. Science. 269(5221):164–169.
  • Teta J, Lau E, Sceurman B, Wagner M. 2007. Therapeutic radiation for lymphoma: risk of malignant mesothelioma. Cancer. 109(7):1432–1438.
  • Tomasetti C, Volgestein B. 2015. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347:78–80.
  • Tomasetti C, Li L, Vogelstein B. 2017. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 355:1330–1334.
  • Travis L, Fossa S, Schonfeld S, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, et al. 2005. Second cancers among 40576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst. 97:1354–1365.
  • Tward J, Wendland M, Shrieve D, Szabo A, Gaffney DK. 2006. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer. 107:108–115.
  • USGS. 2019. Asbestos statistics and information. https://minerals.usgs.gov/minerals/pubs/commodity/asbestos/
  • Vianna NJ, Polan AK. 1978. Non-occupational exposure to asbestos and malignant mesothelioma in females. Lancet. 1(8073):1061–1063.
  • Wagner JC, Sleggs CA, Marchand P. 1960. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Brit J Industr Med. 17:260.
  • Weill H, Hughes JM, Churg AM. 2004. Changing trends in US mesothelioma incidence. Occup Environ Med. 61(5):438–441.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.